5-(3-(1-((6-(2-chloro-4-(methylsulfonamido)phenoxy)-2-methylpyridin-3-yl)methyl)piperidin-4-yl)-3-(3-fluorophenyl)ureido)picolinamide

ID: ALA1914528

PubChem CID: 57403352

Max Phase: Preclinical

Molecular Formula: C32H33ClFN7O5S

Molecular Weight: 682.18

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(Oc2ccc(NS(C)(=O)=O)cc2Cl)ccc1CN1CCC(N(C(=O)Nc2ccc(C(N)=O)nc2)c2cccc(F)c2)CC1

Standard InChI:  InChI=1S/C32H33ClFN7O5S/c1-20-21(6-11-30(37-20)46-29-10-8-23(17-27(29)33)39-47(2,44)45)19-40-14-12-25(13-15-40)41(26-5-3-4-22(34)16-26)32(43)38-24-7-9-28(31(35)42)36-18-24/h3-11,16-18,25,39H,12-15,19H2,1-2H3,(H2,35,42)(H,38,43)

Standard InChI Key:  WMHUXCUGXVXAJP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 47 51  0  0  0  0  0  0  0  0999 V2000
   -4.3042  -18.6375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7125  -17.9250    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1254  -18.6349    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2806  -17.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2818  -18.7523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5669  -19.1652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8505  -18.7519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8534  -17.9213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5687  -17.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1354  -19.1632    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4216  -18.7496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2902  -19.1614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0035  -18.7485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0027  -17.9226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2825  -17.5114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4278  -17.9267    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7160  -17.5080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4316  -17.9185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4293  -18.7470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1409  -19.1574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8566  -18.7463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8562  -17.9203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1401  -17.5054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5707  -19.1594    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5700  -19.9844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2856  -18.7476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9997  -19.1607    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2863  -17.9226    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7145  -18.7488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4246  -19.1651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1389  -18.7540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1401  -17.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4209  -17.5151    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7095  -17.9287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8544  -17.5153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9952  -17.5126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4241  -17.5130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8542  -20.3946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8531  -21.2188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5678  -21.6328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2850  -21.2165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2825  -20.3936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5690  -17.9274    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8540  -16.6903    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2783  -16.6864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1381  -21.6304    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5671  -19.9902    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 22 23  1  0
 11 12  2  0
 21 24  1  0
  6  7  2  0
 24 25  1  0
 12 13  1  0
 24 26  1  0
  2  1  2  0
 26 27  1  0
 13 14  2  0
 26 28  2  0
  7  8  1  0
 27 29  1  0
 14 15  1  0
 29 30  2  0
  4  5  2  0
 30 31  1  0
 15 16  2  0
 31 32  2  0
 16 11  1  0
 32 33  1  0
  8  9  2  0
 33 34  2  0
 34 29  1  0
 14 17  1  0
 32 35  1  0
  9  4  1  0
  4 36  1  0
 36  2  1  0
 17 18  1  0
  2 37  1  0
 18 19  1  0
 25 38  2  0
  3  2  2  0
 38 39  1  0
  7 10  1  0
 39 40  2  0
  5  6  1  0
 40 41  1  0
 10 11  1  0
 41 42  2  0
 42 25  1  0
 35 43  1  0
 18 23  1  0
 35 44  2  0
 19 20  1  0
 15 45  1  0
 20 21  1  0
 39 46  1  0
 21 22  1  0
  6 47  1  0
M  END

Associated Targets(Human)

HOS (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 682.18Molecular Weight (Monoisotopic): 681.1936AlogP: 5.54#Rotatable Bonds: 10
Polar Surface Area: 159.85Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.70CX Basic pKa: 7.44CX LogP: 2.88CX LogD: 2.56
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.20Np Likeness Score: -1.86

References

1. Duan M, Kazmierski WM, Chong PY, Deanda F, Edelstein M, Ferris R, Peckham J, Wheelan P, Xiong Z, Zhang H, Nishizawa R, Takaoka Y..  (2011)  Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats.,  21  (21): [PMID:21920742] [10.1016/j.bmcl.2011.08.080]

Source